Copyright: ©Author(s) 2026.
World J Clin Cases. Aug 26, 2026; 14(24): 123303
Published online Aug 26, 2026. doi: 10.12998/wjcc.123303
Published online Aug 26, 2026. doi: 10.12998/wjcc.123303
Table 1 Key contributions of the multidisciplinary team at major decision nodes
| Treatment stage | Core contributions of MDT |
| Diagnosis | Department of Radiology and Ultrasound interpreted the “fast-in, fast-out” imaging features of the lesion, suggesting the possibility of a neuroendocrine tumor |
| Preoperative | Department of Interventional Radiology performed percutaneous transhepatic cholangiography and drainage to ensure surgical safety; the Department of Surgery formulated the surgical plan for laparoscopic pancreaticoduodenectomy |
| Pathology | Comprehensive immunohistochemical tests (including MMR protein testing) were performed, confirming proficient MMR and excluding indications for immunotherapy |
| Adjuvant therapy | Department of Medical Oncology formulated the EP regimen; the Department of Pathology reconfirmed no indications for immune checkpoint inhibitor therapy |
| Follow-up | Multidisciplinary coordination completed imaging reexamination and clinical efficacy evaluation |
- Citation: Zheng BQ, Wang ZP, Feng RZ, Zheng ZC, Wang HJ, Wang H, Tuo HF. Large cell neuroendocrine carcinoma of the distal common bile duct: A case report and literature review. World J Clin Cases 2026; 14(24): 123303
- URL: https://www.wjgnet.com/2307-8960/full/v14/i24/123303.htm
- DOI: https://dx.doi.org/10.12998/wjcc.123303